Immune Activation in Alzheimer Disease

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Alzheimer disease (AD) is a leading neurodegenerative disorder with increasing burdens.
• Traditionally linked to amyloid-beta (Aβ) plaques and tau tangles, chronic immune activation is now recognized as a key factor in AD pathogenesis.
• Understanding the immune system's role is crucial for developing effective AD treatments.

Purpose of the Study:

• To review recent advances in understanding immune activation in Alzheimer disease.
• To explore the role of microglia and peripheral signals in AD pathogenesis.
• To discuss strategies for studying human microglia in the context of AD.

Main Methods:

• Review of current scientific literature on Alzheimer disease and neuroinflammation.
• Analysis of the mechanisms of microglial activation by Aβ species.
• Discussion of transcriptional changes and heterogeneity of human microglia.

Main Results:

• Microglia, the brain's immune cells, detect and are activated by Aβ species.
• Activated microglia contribute significantly to the pathogenesis of Alzheimer disease.
• Peripheral signals and other cell types also play a role in immune activation in AD.

Conclusions:

• Immune activation, particularly by microglia, is a critical component of Alzheimer disease development.
• Further research into microglial heterogeneity and peripheral immune contributions is essential.
• Targeting immune pathways presents a promising therapeutic avenue for Alzheimer disease.